No Man

Sign in

Join Free
Post RFQ

Cebranopadol

TypeName: Business Offer

Category:

Offer Date:2019/09/04

Country: United States

Summary: Cebranopadol is a novel first-in-class compound with potent agonist activity on opioid receptor like-1(ORL-1) and the well established mu opioid receptor. It showed antinociceptive and antihypertensive effects in a variety of different animal models of pain, suggesting its potential use for the treatment of chronic pain states.
https://www.bocsci.com/cebranopadol-cas-863513-91-1-item-474871.html

Description:

OfferId: 5453

Name:Alex Brown

Telphone:

Email:[email protected]